Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02189174
Title Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
Massachusetts General Hospital SC-9 Boston Massachusetts 02114 United States Details
Memorial Sloan Kettering SC-4 New York New York 10017 United States Details
Tennessee Oncology SC Nashville Tennessee 37203 United States Details
Novartis Investigative Site Toronto Ontario M5G 1X6 Canada Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field